A new interleukin to treat arthrites: anti-interleukin-6

Immunopathological aspects of interleukin-6 are analyzed, as well as the clinical use of tocilizumab, its safety and efficacy. Several studies have demonstrated that the blockade of interleukin-6 may bring a therapeutic benefit to rheumatoid arthritis patients. Tocilizumab is a humanized monoclonal...

Full description

Bibliographic Details
Main Author: Morton Aaron Scheinberg
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2009-03-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://apps.einstein.br/revista/arquivos/PDF/1172-einsteinv7n1p108_11_eng.pdf